Francois Fays
Overview
Explore the profile of Francois Fays including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fays F, Palazzi P, Zeman F, Hardy E, Schaeffer C, Rousselle C, et al.
Environ Sci Technol
. 2023 May;
57(19):7336-7345.
PMID: 37146304
Mechanisms governing chemicals' incorporation in hair are incompletely understood, and gaps remain to link the concentration of chemicals in hair to level of exposure and internal dose present in the...
2.
Roseren C, Binck S, Fays F, Ruiz-Castell M, Samouda H, Appenzeller B
Drug Test Anal
. 2022 Dec;
15(9):962-970.
PMID: 36562126
Despite inititatives to reduce tobacco consumption, smoking remains a primary cause of death for both smokers and nonsmokers exposed to environmental tobacco smoke (ETS). The characteristics of some specific groups...
3.
Fays F, Hardy E, Palazzi P, Haan S, Beausoleil C, Appenzeller B
Sci Total Environ
. 2021 May;
778:146330.
PMID: 34030378
Background: The assessment of human exposure to fast-elimination endocrine disruptors (ED) such as phthalates, bisphenols or pesticides is usually based on urinary biomarkers. The variability of biomarkers concentration, due to...
4.
Grova N, Hardy E, Fays F, Duca R, Appenzeller B
Arch Toxicol
. 2018 Aug;
92(10):3061-3075.
PMID: 30159663
Alongside the analysis of urinary metabolites which are traditional biomarkers of polycyclic aromatic hydrocarbons (PAH) exposure, the possibility of detecting PAH as well as their metabolites in hair has also...
5.
El-Khoury V, Beland M, Schritz A, Kim S, Nazarov P, Gaboury L, et al.
Br J Cancer
. 2018 Aug;
119(5):580-590.
PMID: 30078843
Background: Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the...
6.
Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, et al.
J Stroke
. 2017 Oct;
19(3):323-332.
PMID: 29037006
Background And Purpose: Micro ribonucleic acid-150-5p (miR-150-5p) regulates proinflammatory cytokines as well as vessel integrity. We evaluated the incremental prognostic value of logarithm (log) of miR-150-5p plasma levels after ischemic...
7.
Stammet P, Dankiewicz J, Nielsen N, Fays F, Collignon O, Hassager C, et al.
Crit Care
. 2017 Jun;
21(1):153.
PMID: 28629472
Background: We aimed to investigate the diagnostic performance of S100 as an outcome predictor after out-of-hospital cardiac arrest (OHCA) and the potential influence of two target temperatures (33 °C and...
8.
Appenzeller B, Hardy E, Grova N, Chata C, Fays F, Briand O, et al.
Arch Toxicol
. 2016 Dec;
91(8):2813-2825.
PMID: 28011991
Urine and plasma have been used to date for the biomonitoring of exposure to pollutants and are still the preferred fluids for this purpose; however, these fluids mainly provide information...
9.
Schroeder L, Rufra O, Sauvageot N, Fays F, Pieri V, Diederich N
Sleep
. 2016 Oct;
39(12):2133-2139.
PMID: 27748239
Study Objectives: To explore rapid eye movement density (RD) in patients with idiopathic Parkinson disease (IPD) and to investigate its usefulness as surrogate marker of excessive daytime sleepiness, a frequent...